{
  "Global": {
    "By Product Category": {
      "Originator Molecule": {
        "Lantus": {},
        "Toujeo": {}
      },
      "Biosimilar": {
        "Basaglar/Abasaglar": {},
        "Basalin": {},
        "Glaritus": {},
        "Besugine": {},
        "Other Pipeline Molecules (Ondibta, among others)": {}
      },
      "Combination": {
        "Soliqua": {}
      },
      "Interchangeable": {
        "Semglee": {},
        "Rezvoglar": {}
      }
    },
    "By Form": {
      "Vials": {},
      "Cartridge": {},
      "Prefilled Pen": {}
    },
    "By Concentration": {
      "100 IU": {},
      "300 IU": {}
    },
    "By Application": {
      "Type 1 Diabetes": {},
      "Type 2 Diabetes": {}
    },
    "By Distribution Channel": {
      "Hospital Pharmacies": {},
      "Retail Pharmacies": {},
      "Online Pharmacies": {}
    },
    "By Region": {
      "North America": {
        "U.S.": {},
        "Canada": {}
      },
      "Europe": {
        "U.K.": {},
        "Germany": {},
        "Italy": {},
        "France": {},
        "Spain": {},
        "Russia": {},
        "Rest of Europe": {}
      },
      "Asia Pacific": {
        "China": {},
        "India": {},
        "Japan": {},
        "South Korea": {},
        "ASEAN": {},
        "Australia": {},
        "Rest of Asia Pacific": {}
      },
      "Latin America": {
        "Brazil": {},
        "Argentina": {},
        "Mexico": {},
        "Rest of Latin America": {}
      },
      "Middle East & Africa": {
        "GCC": {},
        "South Africa": {},
        "Rest of Middle East & Africa": {}
      }
    }
  }
}